好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2017 Annual Meeting | C178 - Biomarkers in Dementia

Wednesday 04/26/17
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Beau M. Ances, MD, PhD, MS, FAAN
After completing this course participants should gain an understanding of the differential diagnosis of dementia (e.g. Alzheimer's disease vs. Frontotemporal dementia vs. Vascular dementia vs. Rapidly progressive dementia), potential role for neuropsychology, neuroimaging, and molecular biomarkers in supporting a particular diagnosis, and the management of dementing illnesses.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
03:30 PM - 03:35 PM Luncheon Introduction
Beau M. Ances, MD, PhD, MS, FAAN
03:35 PM - 04:00 PM Speaker Biomarkers in Alzheimer's Disease
Beau M. Ances, MD, PhD, MS, FAAN
04:00 PM - 04:30 PM Speaker Biomarkers in Frontotemporal Dementia and Dementia with Lewy Body
Murray Grossman, MD, FAAN
04:30 PM - 05:00 PM Speaker Biomarkers in Rapidly Progressive Dementia
Gregory S. Day, MD, MSc, FAAN
05:00 PM - 05:20 PM Speaker Biomarkers in Vascular Dementia
Rebecca F. Gottesman, MD
05:20 PM - 05:30 PM Q&A Questions and Answers
Faculty Disclosures
Beau M. Ances, MD, PhD, MS, FAAN Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Ances has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Kinnard Lawyers.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Rebecca F. Gottesman, MD The institution of Dr. Gottesman has received research support from NIH.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.